1h Free Analyst Time
The ophthalmology therapeutics market is forecasted to grow by $15.72 bn during 2022-2027, accelerating at a CAGR of 6.25% during the forecast period. Our report on the ophthalmology therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in the prevalence of eye diseases, approval of novel therapeutics and strong drug pipeline, and strong uptake of anti-VEGF inhibitors.
The ophthalmology therapeutics market is segmented as below:
By Product
- Retinal disorder
- Glaucoma
- Dry eye disease
- Eye infections and inflammation
- Other therapeutics
By Type
- Prescription drugs
- OTC drugs
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the ophthalmology therapeutics market covers the following areas:
- Ophthalmology therapeutics market sizing
- Ophthalmology therapeutics market forecast
- Ophthalmology therapeutics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global ophthalmology therapeutics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global ophthalmology therapeutics market 2017 - 2021 ($ billion)
4.2 Product Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Retinal disorder therapeutics - Market size and forecast 2022-2027
Exhibit 34: Chart on Retinal disorder therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 35: Data Table on Retinal disorder therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 36: Chart on Retinal disorder therapeutics - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Retinal disorder therapeutics - Year-over-year growth 2022-2027 (%)
6.4 Glaucoma therapeutics - Market size and forecast 2022-2027
Exhibit 38: Chart on Glaucoma therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 39: Data Table on Glaucoma therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 40: Chart on Glaucoma therapeutics - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Glaucoma therapeutics - Year-over-year growth 2022-2027 (%)
6.5 Dry eye disease therapeutics - Market size and forecast 2022-2027
Exhibit 42: Chart on Dry eye disease therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 43: Data Table on Dry eye disease therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 44: Chart on Dry eye disease therapeutics - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Dry eye disease therapeutics - Year-over-year growth 2022-2027 (%)
6.6 Eye infections and inflammation therapeutics - Market size and forecast 2022-2027
Exhibit 46: Chart on Eye infections and inflammation therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 47: Data Table on Eye infections and inflammation therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 48: Chart on Eye infections and inflammation therapeutics - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Eye infections and inflammation therapeutics - Year-over-year growth 2022-2027 (%)
6.7 Other therapeutics - Market size and forecast 2022-2027
Exhibit 50: Chart on Other therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 51: Data Table on Other therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibit 52: Chart on Other therapeutics - Year-over-year growth 2022-2027 (%)
Exhibit 53: Data Table on Other therapeutics - Year-over-year growth 2022-2027 (%)
6.8 Market opportunity by Product
Exhibit 54: Market opportunity by Product ($ billion)
7 Market Segmentation by Type
7.1 Market segments
Exhibit 55: Chart on Type - Market share 2022-2027 (%)
Exhibit 56: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 57: Chart on Comparison by Type
Exhibit 58: Data Table on Comparison by Type
7.3 Prescription drugs - Market size and forecast 2022-2027
Exhibit 59: Chart on Prescription drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 60: Data Table on Prescription drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 61: Chart on Prescription drugs - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Prescription drugs - Year-over-year growth 2022-2027 (%)
7.4 OTC drugs - Market size and forecast 2022-2027
Exhibit 63: Chart on OTC drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 64: Data Table on OTC drugs - Market size and forecast 2022-2027 ($ billion)
Exhibit 65: Chart on OTC drugs - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on OTC drugs - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Type
Exhibit 67: Market opportunity by Type ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 71: Chart on Geographic comparison
Exhibit 72: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 France - Market size and forecast 2022-2027
Exhibit 101: Chart on France - Market size and forecast 2022-2027 ($ billion)
Exhibit 102: Data Table on France - Market size and forecast 2022-2027 ($ billion)
Exhibit 103: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on France - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 105: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 106: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibit 107: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 108: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 109: Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 110: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 112: Overview on factors of disruption
11.4 Industry risks
Exhibit 113: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 114: Vendors covered
12.2 Market positioning of vendors
Exhibit 115: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 116: AbbVie Inc. - Overview
Exhibit 117: AbbVie Inc. - Product / Service
Exhibit 118: AbbVie Inc. - Key news
Exhibit 119: AbbVie Inc. - Key offerings
12.4 Aldeyra Therapeutics Inc.
Exhibit 120: Aldeyra Therapeutics Inc. - Overview
Exhibit 121: Aldeyra Therapeutics Inc. - Product / Service
Exhibit 122: Aldeyra Therapeutics Inc. - Key offerings
12.5 Bausch Health Co Inc.
Exhibit 123: Bausch Health Co Inc. - Overview
Exhibit 124: Bausch Health Co Inc. - Business segments
Exhibit 125: Bausch Health Co Inc. - Key news
Exhibit 126: Bausch Health Co Inc. - Key offerings
Exhibit 127: Bausch Health Co Inc. - Segment focus
12.6 Bayer AG
Exhibit 128: Bayer AG - Overview
Exhibit 129: Bayer AG - Business segments
Exhibit 130: Bayer AG - Key news
Exhibit 131: Bayer AG - Key offerings
Exhibit 132: Bayer AG - Segment focus
12.7 F. Hoffmann La Roche Ltd.
Exhibit 133: F. Hoffmann La Roche Ltd. - Overview
Exhibit 134: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 135: F. Hoffmann La Roche Ltd. - Key news
Exhibit 136: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 137: F. Hoffmann La Roche Ltd. - Segment focus
12.8 Novartis AG
Exhibit 138: Novartis AG - Overview
Exhibit 139: Novartis AG - Business segments
Exhibit 140: Novartis AG - Key offerings
Exhibit 141: Novartis AG - Segment focus
12.9 Ocular Therapeutix Inc.
Exhibit 142: Ocular Therapeutix Inc. - Overview
Exhibit 143: Ocular Therapeutix Inc. - Product / Service
Exhibit 144: Ocular Therapeutix Inc. - Key offerings
12.10 Otsuka Pharmaceutical Co. Ltd.
Exhibit 145: Otsuka Pharmaceutical Co. Ltd. - Overview
Exhibit 146: Otsuka Pharmaceutical Co. Ltd. - Product / Service
Exhibit 147: Otsuka Pharmaceutical Co. Ltd. - Key offerings
12.11 Oxurion NV
Exhibit 148: Oxurion NV - Overview
Exhibit 149: Oxurion NV - Product / Service
Exhibit 150: Oxurion NV - Key offerings
12.12 Pfizer Inc.
Exhibit 151: Pfizer Inc. - Overview
Exhibit 152: Pfizer Inc. - Product / Service
Exhibit 153: Pfizer Inc. - Key news
Exhibit 154: Pfizer Inc. - Key offerings
12.13 Regeneron Pharmaceuticals Inc.
Exhibit 155: Regeneron Pharmaceuticals Inc. - Overview
Exhibit 156: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibit 157: Regeneron Pharmaceuticals Inc. - Key offerings
12.14 Santen Pharmaceutical Co. Ltd.
Exhibit 158: Santen Pharmaceutical Co. Ltd. - Overview
Exhibit 159: Santen Pharmaceutical Co. Ltd. - Product / Service
Exhibit 160: Santen Pharmaceutical Co. Ltd. - Key offerings
12.15 Sun Pharmaceutical Industries Ltd.
Exhibit 161: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 162: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 163: Sun Pharmaceutical Industries Ltd. - Key offerings
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 164: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 165: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 166: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 167: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 168: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Visufarma
Exhibit 169: Visufarma - Overview
Exhibit 170: Visufarma - Product / Service
Exhibit 171: Visufarma - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 172: Inclusions checklist
Exhibit 173: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 174: Currency conversion rates for US$
13.4 Research methodology
Exhibit 175: Research methodology
Exhibit 176: Validation techniques employed for market sizing
Exhibit 177: Information sources
13.5 List of abbreviations
Exhibit 178: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global ophthalmology therapeutics market 2017 - 2021 ($ billion)
Exhibits 19: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
Exhibits 20: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Product - Market share 2022-2027 (%)
Exhibits 31: Data Table on Product - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Product
Exhibits 33: Data Table on Comparison by Product
Exhibits 34: Chart on Retinal disorder therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits 35: Data Table on Retinal disorder therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits 36: Chart on Retinal disorder therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Retinal disorder therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Glaucoma therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits 39: Data Table on Glaucoma therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits 40: Chart on Glaucoma therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Glaucoma therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Dry eye disease therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits 43: Data Table on Dry eye disease therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits 44: Chart on Dry eye disease therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Dry eye disease therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits 46: Chart on Eye infections and inflammation therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits 47: Data Table on Eye infections and inflammation therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits 48: Chart on Eye infections and inflammation therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits 49: Data Table on Eye infections and inflammation therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits 50: Chart on Other therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits 51: Data Table on Other therapeutics - Market size and forecast 2022-2027 ($ billion)
Exhibits 52: Chart on Other therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits 53: Data Table on Other therapeutics - Year-over-year growth 2022-2027 (%)
Exhibits 54: Market opportunity by Product ($ billion)
Exhibits 55: Chart on Type - Market share 2022-2027 (%)
Exhibits 56: Data Table on Type - Market share 2022-2027 (%)
Exhibits 57: Chart on Comparison by Type
Exhibits 58: Data Table on Comparison by Type
Exhibits 59: Chart on Prescription drugs - Market size and forecast 2022-2027 ($ billion)
Exhibits 60: Data Table on Prescription drugs - Market size and forecast 2022-2027 ($ billion)
Exhibits 61: Chart on Prescription drugs - Year-over-year growth 2022-2027 (%)
Exhibits 62: Data Table on Prescription drugs - Year-over-year growth 2022-2027 (%)
Exhibits 63: Chart on OTC drugs - Market size and forecast 2022-2027 ($ billion)
Exhibits 64: Data Table on OTC drugs - Market size and forecast 2022-2027 ($ billion)
Exhibits 65: Chart on OTC drugs - Year-over-year growth 2022-2027 (%)
Exhibits 66: Data Table on OTC drugs - Year-over-year growth 2022-2027 (%)
Exhibits 67: Market opportunity by Type ($ billion)
Exhibits 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 71: Chart on Geographic comparison
Exhibits 72: Data Table on Geographic comparison
Exhibits 73: Chart on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits 74: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
Exhibits 75: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 77: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits 78: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
Exhibits 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 81: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits 82: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
Exhibits 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
Exhibits 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 89: Chart on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 90: Data Table on US - Market size and forecast 2022-2027 ($ billion)
Exhibits 91: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 92: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 93: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits 94: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
Exhibits 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 97: Chart on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits 98: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
Exhibits 99: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 101: Chart on France - Market size and forecast 2022-2027 ($ billion)
Exhibits 102: Data Table on France - Market size and forecast 2022-2027 ($ billion)
Exhibits 103: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits 104: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits 105: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits 106: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
Exhibits 107: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 108: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 109: Market opportunity By Geographical Landscape ($ billion)
Exhibits 110: Impact of drivers and challenges in 2022 and 2027
Exhibits 111: Overview on Criticality of inputs and Factors of differentiation
Exhibits 112: Overview on factors of disruption
Exhibits 113: Impact of key risks on business
Exhibits 114: Vendors covered
Exhibits 115: Matrix on vendor position and classification
Exhibits 116: AbbVie Inc. - Overview
Exhibits 117: AbbVie Inc. - Product / Service
Exhibits 118: AbbVie Inc. - Key news
Exhibits 119: AbbVie Inc. - Key offerings
Exhibits 120: Aldeyra Therapeutics Inc. - Overview
Exhibits 121: Aldeyra Therapeutics Inc. - Product / Service
Exhibits 122: Aldeyra Therapeutics Inc. - Key offerings
Exhibits 123: Bausch Health Co Inc. - Overview
Exhibits 124: Bausch Health Co Inc. - Business segments
Exhibits 125: Bausch Health Co Inc. - Key news
Exhibits 126: Bausch Health Co Inc. - Key offerings
Exhibits 127: Bausch Health Co Inc. - Segment focus
Exhibits 128: Bayer AG - Overview
Exhibits 129: Bayer AG - Business segments
Exhibits 130: Bayer AG - Key news
Exhibits 131: Bayer AG - Key offerings
Exhibits 132: Bayer AG - Segment focus
Exhibits 133: F. Hoffmann La Roche Ltd. - Overview
Exhibits 134: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 135: F. Hoffmann La Roche Ltd. - Key news
Exhibits 136: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 137: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 138: Novartis AG - Overview
Exhibits 139: Novartis AG - Business segments
Exhibits 140: Novartis AG - Key offerings
Exhibits 141: Novartis AG - Segment focus
Exhibits 142: Ocular Therapeutix Inc. - Overview
Exhibits 143: Ocular Therapeutix Inc. - Product / Service
Exhibits 144: Ocular Therapeutix Inc. - Key offerings
Exhibits 145: Otsuka Pharmaceutical Co. Ltd. - Overview
Exhibits 146: Otsuka Pharmaceutical Co. Ltd. - Product / Service
Exhibits 147: Otsuka Pharmaceutical Co. Ltd. - Key offerings
Exhibits 148: Oxurion NV - Overview
Exhibits 149: Oxurion NV - Product / Service
Exhibits 150: Oxurion NV - Key offerings
Exhibits 151: Pfizer Inc. - Overview
Exhibits 152: Pfizer Inc. - Product / Service
Exhibits 153: Pfizer Inc. - Key news
Exhibits 154: Pfizer Inc. - Key offerings
Exhibits 155: Regeneron Pharmaceuticals Inc. - Overview
Exhibits 156: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibits 157: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibits 158: Santen Pharmaceutical Co. Ltd. - Overview
Exhibits 159: Santen Pharmaceutical Co. Ltd. - Product / Service
Exhibits 160: Santen Pharmaceutical Co. Ltd. - Key offerings
Exhibits 161: Sun Pharmaceutical Industries Ltd. - Overview
Exhibits 162: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibits 163: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibits 164: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 165: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 166: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 167: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 168: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 169: Visufarma - Overview
Exhibits 170: Visufarma - Product / Service
Exhibits 171: Visufarma - Key offerings
Exhibits 172: Inclusions checklist
Exhibits 173: Exclusions checklist
Exhibits 174: Currency conversion rates for US$
Exhibits 175: Research methodology
Exhibits 176: Validation techniques employed for market sizing
Exhibits 177: Information sources
Exhibits 178: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global ophthalmology therapeutics market: AbbVie Inc., Adrif Vision, Aldeyra Therapeutics Inc., Bausch Health Co Inc., Bayer AG, Eyeris Vision Care Pvt. Ltd., F. Hoffmann La Roche Ltd., Grevis Pharmaceuticals Pvt. Ltd., Novartis AG, Ocular Therapeutix Inc., Otsuka Pharmaceutical Co. Ltd., Oxurion NV, Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., Swissvision, Teva Pharmaceutical Industries Ltd., Vee Remedies, and Visufarma.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is development of novel drug delivery systems.`
According to the report, one of the major drivers for this market is the increase in the prevalence of eye diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Adrif Vision
- Aldeyra Therapeutics Inc.
- Bausch Health Co Inc.
- Bayer AG
- Eyeris Vision Care Pvt. Ltd.
- F. Hoffmann La Roche Ltd.
- Grevis Pharmaceuticals Pvt. Ltd.
- Novartis AG
- Ocular Therapeutix Inc.
- Otsuka Pharmaceutical Co. Ltd.
- Oxurion NV
- Pfizer Inc.
- Regeneron Pharmaceuticals Inc.
- Santen Pharmaceutical Co. Ltd.
- Sun Pharmaceutical Industries Ltd.
- Swissvision
- Teva Pharmaceutical Industries Ltd.
- Vee Remedies
- Visufarma
